SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001214659-24-005077
Filing Date
2024-03-25
Accepted
2024-03-25 16:45:25
Documents
6
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 p322246def14a.htm DEF 14A 525508
2 GRAPHIC alzamendlogo_regmark.jpg GRAPHIC 17222
3 GRAPHIC compchart_netloss.jpg GRAPHIC 72495
4 GRAPHIC compchart_totalsharereturn.jpg GRAPHIC 78488
5 GRAPHIC proxy-001.jpg GRAPHIC 116159
6 GRAPHIC proxy-002.jpg GRAPHIC 119007
  Complete submission text file 0001214659-24-005077.txt   1082741
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-40483 | Film No.: 24779864
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)